| Literature DB >> 17347992 |
Samuel A Wickline1, Anne M Neubauer, Patrick M Winter, Shelton D Caruthers, Gregory M Lanza.
Abstract
Advances in bionanotechnology are poised to impact the field of cardiovascular diagnosis and therapy for decades to come. This review seeks to illustrate selected examples of newly developed diagnostic and therapeutic nanosystems that have been evaluated in experimental atherosclerosis, thrombosis, and vascular biology. We review a variety of nanotechnologies that are capable of detecting early cardiovascular pathology, as well as associated imaging approaches and conjunctive strategies for site-targeted treatment with nanoparticle delivery systems. Copyright (c) 2007 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17347992 DOI: 10.1002/jmri.20866
Source DB: PubMed Journal: J Magn Reson Imaging ISSN: 1053-1807 Impact factor: 4.813